Last reviewed · How we verify

NCT04258267: FINOSA

Which Factors Influence the Outcome After Anatomical and Reverse Shoulder Arthroplasty?

Recruiting now NA Last updated 9 May 2024
What this trial tests

NA trial testing Early mobilization in Arthroplasty, Replacement, Shoulder in 97 participants. Currently enrolling.

Timeline
14 January 2020
Primary endpoint
30 April 2025
14 September 2025

Quick facts

Lead sponsorUniversiteit Antwerpen
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment97
Start date14 January 2020
Primary completion30 April 2025
Estimated completion14 September 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Universiteit Antwerpen — full company profile →

Who can join

18 and older, any sex, with Arthroplasty, Replacement, Shoulder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate pre-, intra- and post-operative factors that influence post-operative outcome (shoulder pain, shoulder function and quality of life) after shoulder arthroplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Factors Influencing Outcome After Shoulder Arthroplasty (FINOSA Study): Protocol of a Prospective Longitudinal Study With Randomized Group Allocation.
    Claes A, De Mesel A, Struyf T, Verborgt O, et al · · 2024 · cited 2× · PMID 39556824 · DOI 10.2196/56522

Verify or expand the search:

Other trials of Early mobilization

Trials testing the same drug.

Other recruiting trials for Arthroplasty, Replacement, Shoulder

Currently open trials in the same condition.

Other Universiteit Antwerpen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04258267.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing